Clinical Trials Browser

Leukemia, Lymphoid × pembrolizumab × 90 days × Clear all

NCT03219450 2026-05-28

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Lymphoid